MARATTO

article · Life Sciences

Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway

202310 citationsBadr University in Cairo

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Cardiac Fibrosis and Remodeling
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.lfs.2023.122354

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.